The enhanced oncogenicity of particular human papillomavirus type 16 (HPV16) E6 variants is population-dependent, implying the involvement of additional genetic cofactors. This study was designed to investigate the association between E6 variants and human leukocyte antigen (HLA) polymorphism within
HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer
✍ Scribed by Yuping Wu; Benrong Liu; Wenzhi Lin; Yunping Xu; Longyu Li; Yanling Zhang; Shangwu Chen; Anlong Xu
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 116 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Infection with human papillomavirus type 16 (HPV16) confers a high risk for the development of cervical cancer. Variants of this virus may interact differentially with host genetic factors, possibly affecting the disease pathogenesis. This study was designed to investigate the association between HPV16 E6 variants and human leukocyte antigen (HLA) polymorphism within a Chinese population. Peripheral blood from HPV16 positive Chinese women with cervical carcinoma, who had previously been tested for HPV16 E6 variants, was used for HLA class II typing. It was found that there was a significant positive association between DQB1*060101 allele and HPV16 As variant‐positive cervical cancers (OR, 4.47; __P__c = 0.0018). A negative relationship was found between DRB1*150101‐DQB1*0602 haplotype and decreased risk for HPV16 As variant‐positive cervical cancers (OR = 0.31; P = 0.037). Similar tendency was observed for the haplotype DRB1*070101‐DQB1*0201 with HPV16 As variant‐positive cervical cancers (OR = 0.16, P = 0.024). Additionally, as for the HPV16 E6 prototype‐positive cervical cancers, a significant positive association was found in DQB1*060101 allele (OR = 5.95; P = 0.002; __P__c = 0.036), and similar trends were observed for DQB1*030201 (OR = 10.87, P < 0.0001; __P__c = 0.0018), and DPB1*1301(OR = 7.40, P = 0.002; __P__c = 0.04). It was found that there was no significant association between DRB1‐DQB1 haplotype and HPV16 prototype‐positive cervical cancers. These data indicate that host genetic factors, such as HLA polymorphism, may determine the potential oncogenicity of the HPV16 E6 variant. The results suggest that a specific match between E6 variant proteins and HLA class II alleles may contribute to HPV16‐related cervical carcinogenesis in a certain Chinese population. J. Med. Virol. 79:439–446, 2007. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
HLA class II alleles have been associated with an increased risk of developing cervical cancer through infection with oncogenic forms of human papilloma virus (HPV). We have examined the association of variation at the DRB1 and DQB1 loci with HPV16 infection and risk of development of cervical cance
High-risk human papillomaviruses (HPV), particularly HPV 16, are associated with invasive cervical cancer (ICC), and persistent high-risk HPV infection is considered to be a marker for progressive cervical intra-epithelial neoplasia (CIN). However, most high-risk, HPV-infected, pre-cancerous lesions
Infection with high-risk human papillomavirus (HPV) is necessary for the development of a cervical lesion, but only a fraction of precursor lesions progress to cancer. Additional factors, other than HPV type per se, are likely to increase the probability for progression. Intratype genome variations